Previous studies have suggested that DMDD shows significant antitumor potential against human breast cancer by inhibiting the TLR4/MyD88/NF-κB (Lu et al., 2019) and MAPK pathway (Zhou et al., 2020) in vitro (Chen et al., 2017) and in vivo. The gene discussed is NFKB1; the disease is breast carcinoma.